Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, March 2000, p. 651-653, Vol. 44, No. 3
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Inhibition of Inositol Phosphorylceramide Synthase by
Aureobasidin A in Candida and Aspergillus
Species
Wenyan
Zhong,
Matthew W.
Jeffries, and
Nafsika H.
Georgopapadakou*
Experimental Station, DuPont Pharmaceuticals
Company, Wilmington, Delaware 19880-0400
Received 25 October 1999/Returned for modification 30 November
1999/Accepted 20 December 1999
Inositol phosphorylceramide (IPC) synthase is an enzyme common to
fungi and plants that catalyzes the transfer of phosphoinositol from
phosphatidylinositol to ceramide to form IPC. The reaction is a key
step in fungal sphingolipid biosynthesis and the target of the
antibiotics galbonolide A, aureobasidin A, and khafrefungin. As a first
step toward understanding the antifungal spectrum of IPC synthase
inhibitors, we examined the sensitivity of IPC synthase to aureobasidin
A in membrane preparations of Candida species (Candida albicans, C. glabrata, C. tropicalis, C. parapsilosis, and C. krusei) and Aspergillus species (Aspergillus
fumigatus, A. flavus, A. niger, and
A. terreus). As expected, preparations from the five
Candida species, all exquisitely susceptible to aureobasidin A (MICs, <2 µg/ml), had IPC synthase activity (specific activity, 50 to 400 pmol/min/mg of protein) sensitive to
aureobasidin A (50% inhibitory concentrations [IC50s], 2 to 4 ng/ml). Surprisingly, preparations from the four
Aspergillus species, including A. fumigatus and
A. flavus, which are intrinsically resistant to
aureobasidin A (MICs, >50 µg/ml), had IPC synthase activity
(specific activity, 1 to 3 pmol/min/mg of protein) also sensitive to
aureobasidin A (IC50s, 3 to 5 ng/ml). The mammalian
multidrug resistance modulators verapamil, chlorpromazine, and
trifluoperazine lowered the MIC of aureobasidin A for A. fumigatus from >50 µg/ml to 2 to 3 µg/ml, suggesting that
the resistance of this major fungal pathogen is the result of increased efflux.
*
Corresponding author. Mailing address: DuPont
Pharmaceuticals Company, Experimental Station, E400/3456A, P.O. Box
80400, Wilmington, DE 19880-0400. Phone: (302) 695-8525. Fax: (302)
695-7407. E-mail: nafsika.h.dakou{at}dupontpharma.com.
Antimicrobial Agents and Chemotherapy, March 2000, p. 651-653, Vol. 44, No. 3
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Aeed, P. A., Young, C. L., Nagiec, M. M., Elhammer, A. P.
(2009). Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A. Antimicrob. Agents Chemother.
53: 496-504
[Abstract]
[Full Text]
-
Castle, S. A., Owuor, E. A., Thompson, S. H., Garnsey, M. R., Klutts, J. S., Doering, T. L., Levery, S. B.
(2008). {beta}1,2-Xylosyltransferase Cxt1p Is Solely Responsible for Xylose Incorporation into Cryptococcus neoformans Glycosphingolipids. Eukaryot Cell
7: 1611-1615
[Abstract]
[Full Text]
-
Simenel, C., Coddeville, B., Delepierre, M., Latge, J.-P., Fontaine, T.
(2008). Glycosylinositolphosphoceramides in Aspergillus Fumigatus. Glycobiology
18: 84-96
[Abstract]
[Full Text]
-
Gutierrez, A. L., Farage, L., Melo, M. N, Mohana-Borges, R. S, Guerardel, Y., Coddeville, B., Wieruszeski, J.-M., Mendonca-Previato, L., Previato, J. O
(2007). Characterization of glycoinositolphosphoryl ceramide structure mutant strains of Cryptococcus neoformans. Glycobiology
17: 1C-1C
[Abstract]
[Full Text]
-
Li, S., Bao, D., Yuen, G., Harris, S. D., Calvo, A. M.
(2007). basA Regulates Cell Wall Organization and Asexual/Sexual Sporulation Ratio in Aspergillus nidulans. Genetics
176: 243-253
[Abstract]
[Full Text]
-
Heung, L. J., Luberto, C., Del Poeta, M.
(2006). Role of Sphingolipids in Microbial Pathogenesis. Infect. Immun.
74: 28-39
[Full Text]
-
Swamy, B. M., Bhat, A. G., Hegde, G. V., Naik, R. S., Kulkarni, S., Inamdar, S. R.
(2004). Immunolocalization and functional role of Sclerotium rolfsii lectin in development of fungus by interaction with its endogenous receptor. Glycobiology
14: 951-957
[Abstract]
[Full Text]
-
Aoki, K., Uchiyama, R., Yamauchi, S., Katayama, T., Itonori, S., Sugita, M., Hada, N., Yamada-Hada, J., Takeda, T., Kumagai, H., Yamamoto, K.
(2004). Newly Discovered Neutral Glycosphingolipids in Aureobasidin A-resistant Zygomycetes: IDENTIFICATION OF A NOVEL FAMILY OF GALA-SERIES GLYCOLIPIDS WITH CORE Gal{alpha}1-6Gal{beta}1-6Gal{beta} SEQUENCES. J. Biol. Chem.
279: 32028-32034
[Abstract]
[Full Text]
-
Bennion, B., Park, C., Fuller, M., Lindsey, R., Momany, M., Jennemann, R., Levery, S. B.
(2003). Glycosphingolipids of the model fungus Aspergillus nidulans: characterization of GIPCs with oligo-{alpha}-mannose-type glycans. J. Lipid Res.
44: 2073-2088
[Abstract]
[Full Text]
-
Trinel, P.-A., Maes, E., Zanetta, J.-P., Delplace, F., Coddeville, B., Jouault, T., Strecker, G., Poulain, D.
(2002). Candida albicans Phospholipomannan, a New Member of the Fungal Mannose Inositol Phosphoceramide Family. J. Biol. Chem.
277: 37260-37271
[Abstract]
[Full Text]